Mireia Mallandrich
Overview
Explore the profile of Mireia Mallandrich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
258
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mohammadi-Meyabadi R, Mallandrich M, Beirampour N, Garros N, Espinoza L, Sosa L, et al.
Pharmaceutics
. 2024 Oct;
16(10).
PMID: 39458616
Background: Baricitinib, commonly used for autoimmune diseases, is typically administered orally, which can lead to systemic adverse effects. A topical formulation could potentially offer localized therapeutic effects while minimizing these...
2.
Perez-Gonzalez N, Morales-Molina J, Calpena-Campmany A, Halbaut L, Rodriguez-Lagunas M, Febrer N, et al.
Pharm Dev Technol
. 2024 Oct;
29(9):1042-1063.
PMID: 39387661
Aim: Oral candidiasis is often challenging due to limited effectiveness of topical treatments. This study aimed to develop novel caspofungin formulations for administration onto the oral mucosa to enhance drug...
3.
Loza-Rodriguez N, Millan-Sanchez A, Mallandrich M, Calpena A, Lopez O
Pharmaceutics
. 2024 Sep;
16(9).
PMID: 39339223
This study explores the incorporation of 10% 3-O-ethyl L-ascorbic acid (ETVC), a derivative of vitamin C, into two lipid gel systems: a hydrogel (HG) consisting exclusively of lipids and water...
4.
Shahalaei M, Azad A, Sulaiman W, Derakhshani A, Mofakham E, Mallandrich M, et al.
Front Chem
. 2024 Aug;
12:1398979.
PMID: 39206442
Metallic nanoparticles (MNPs) have garnered significant attention due to their ability to improve the therapeutic index of medications by reducing multidrug resistance and effectively delivering therapeutic agents through active targeting....
5.
Beirampour N, Bustos-Salgado P, Garros N, Mohammadi-Meyabadi R, Domenech O, Suner-Carbo J, et al.
Pharmaceutics
. 2024 Aug;
16(8).
PMID: 39204436
Topical ocular drug delivery faces several challenges due to the eye's unique anatomy and physiology. Physiological barriers, tear turnover, and blinking hinder the penetration of drugs through the ocular mucosa....
6.
El Bejjaji S, Ramos-Yacasi G, Suner-Carbo J, Mallandrich M, Gorsek L, Quilchez C, et al.
Gels
. 2024 Jun;
10(6).
PMID: 38920910
Nanocomposite gels consist of nanoparticles dispersed in a gel matrix. The main aim of this work was to develop nanocomposite gels for topical delivery of Flurbiprofen (FB) for humans and...
7.
De Grau-Bassal G, Mallandrich M, Sosa L, Espinoza L, Calpena A, Febrer N, et al.
Pharmaceutics
. 2024 May;
16(5).
PMID: 38794305
Recently, the number of people acquiring tattoos has increased, with tattoos gaining significant popularity in people between 20 and 40 years old. Inflammation is a common reaction associated with tattooing....
8.
Galocha-Leon C, Antich C, Voltes-Martinez A, Marchal J, Mallandrich M, Halbaut L, et al.
Drug Deliv Transl Res
. 2024 Apr;
15(1):291-311.
PMID: 38662335
Three-dimensional (3D) bioprinting is considered one of the most advanced tools to build up materials for tissue engineering. The aim of this work was the design, development and characterization of...
9.
Folle C, Diaz-Garrido N, Mallandrich M, Suner-Carbo J, Sanchez-Lopez E, Halbaut L, et al.
Gels
. 2024 Feb;
10(2).
PMID: 38391479
Thyme oil (THO) possesses excellent antibacterial and antioxidant properties which are suitable for skin inflammatory disorders such as acne vulgaris. However, THO is insoluble in water and its components are...
10.
Folle C, Marques A, Diaz-Garrido N, Carvajal-Vidal P, Lopez E, Suner-Carbo J, et al.
Int J Nanomedicine
. 2024 Feb;
19:1225-1248.
PMID: 38348173
Purpose: is one of the most prevalent dermal disorders affecting skin health and appearance. To date, there is no effective cure for this pathology, and the majority of marketed formulations...